Purpose There is no clinical consensus for the treatment of Keratocystic Odontogenic Tumor (KCOT). KCOTs are regarded as benign aggressive tumors and resection is usually considered as a last option. We review the clinical indications for resection based on a case series. Methods This is a retrospective study of patients with KCOT treated in a single unit over 17 years. Eighty patients were identified, of which 12 (15 %) underwent resection. The remaining 68 patients were managed by enucleation and curettage, enucleation with peripheral ostectomy, or decompression with secondary enucleation. Data extracted includes gender, age, race, location, previous treatment for the lesion, surgery and outcome/ follow up. Results Twelve patients treated by resection were identified. The location in the ten benign resected KCOTs was either the mandibular ramus or the posterior maxilla. All mandibular KCOTs exhibited perforation of the lingual plate and involvement of the pterygoid musculature. Seven of the ten cases were recurrent KCOTs and three had no prior treatment. Two had malignant changes in the KCOT and were also resected. Conclusion The primary reason for resection of KCOT was involvement of the pterygoid muscles. The presence of malignant change was a separate indication for resection.
Introduction
Although traditionally known as Odontogenic Keratocyst this lesion was reclassified as Keratocystic Odontogenic Tumor (KCOT) by the World Health organization in 2005, to better reflect its nature as a neoplasm based both on its clinical behavior and its molecular biology [1] . In a study of 695 consecutive odontogenic cysts 19.1 % were diagnosed as odontogenic keratocysts (OKC) [2] . KCOTs are most common in the third decade (average 30.8-32.8 years), in men and in the mandible (70.5-76.5 %) [3, 4] . They are regarded as aggressive because of their high rates of recurrence and potential to destroy bone and involve adjacent soft tissues. There is much debate regarding the frequency of recurrence and the clinical factors predisposing to this. In two recently reported large series of 256 cases [3] and 183 cases [4] recurrence rates were 58.3 and 13.1 % respectively with significantly higher rates of recurrence in the mandibular angle in the first study and the maxilla in the other study.
Despite their benign classification, molecular analysis of the expression of PTCH, SMO, GlI-1 and bcl-2 in KCOT shows a profile similar to ameloblastoma rather than other odontogenic cysts [5] . In 1994 Jackson et al. [6] reported 2 cases of OKC which invaded and penetrated the skull base and led to the death of one of the patients. The authors emphasize that ''complete excision should be carried out once these unpredictable lesions show any sign of soft tissue involvement. En-bloc resection of the specimen with a layer of surrounding normal tissue may seem 'radical' but it ensures total removal.'' A similar case with intracranial involvement is reported in the French literature [7] .
In addition to its inherent aggressive nature, KCOT may rarely undergo malignant change with an incidence of 0.13-2 % [8] . In 2002, a review of the literature identified only 12 cases of squamous cell carcinoma arising in keratocysts [9] . Although few would disagree with resection for KCOT with malignant change, the indications for resection of the benign KCOT is not well defined in the literature. This retrospective review examines the decision making process in 12 cases of KCOT which were managed with resection.
Patients and Methods
A retrospective chart review of all patients with a diagnosis of OKC/KCOT treated between 1994 and 2011 at the University of Maryland in the Department of Oral and Maxillofacial Surgery was undertaken. IRB exemption was granted for this study (HP-00059568). Data extracted included gender, age, race, location, previous treatment, surgery and outcome/follow up. Twelve patients who underwent resection were identified and form the case series presented. The justifications for resection were analyzed for the cohort to identify any common factors and to establish treatment guidelines.
Results
Eighty patients with KCOT treated between January 1994 and December 2010 were identified, of which 12 (15 %) underwent resection. The remaining 68 patients were managed by enucleation and curettage, enucleation with peripheral ostectomy, or decompression with secondary enucleation.
Data from the 12 patients treated by resection are shown ( Table 1) . Eight of 10 benign KCOTs were in the mandible and involved the vertical ramus with involvement of coronoid/condyle plus extension through the lingual plate into the medial pterygoid muscle. Two extended to the skull base. Six cases were recurrent; two patients had undergone a previous surgery, one patient had undergone 2 previous surgeries, and three patients had undergone 3 or more previous surgeries. These patients had been treated for 7-30 years prior to resection (average 18.5 years).
In the 8 patients with mandibular KCOT, 3 had segmental resection with fibular flap reconstruction, 2 had segmental resection with posterior iliac crest bone graft reconstruction, 1 had segmental resection and a costochondral rib graft reconstruction, and 1 had segmental resection and a reconstruction plate only. The other patient in this group had a resection of the posterior ramus of the mandible but mandibular continuity was maintained so this represented a marginal resection. Follow up was problematic in this cohort with periods of 2, 5, 7, 30, 40, 108, 111, and 168 months (average 58.4 months). Although the average follow up is approximately 5 years, 2 patients were followed for \6 months and only 3 of 7 had long term follow up of more than 5 years. Although no recurrent lesions were seen, the follow up was short except for 3 of our cases.
There was significant morbidity in 4 of 7 patients besides the expected ipsilateral inferior alveolar nerve anesthesia from segmental resection. Case 1 had ipsilateral lingual paresthesia and paresthesia of the lateral side of her foot, Case 5 required prolonged ventilation following pulmonary complications following resection and fibular flap, Case 7 had weakness of the mandibular branch of the facial nerve and fractured his plate 8 years post operatively which required replacement and Case 8 lost her bone graft following an infection and required her reconstruction plate replaced 15 months post-operatively.
The 2 maxillary KCOTs were both in the posterior maxilla and extended into the pterygoid plates (Fig. 1) . One patient had 2 previous surgeries over a period of 21 years and the other patient was previously untreated. Both were treated by posterior maxillectomy with buccal fat pad reconstruction. Neither patient followed up[6 months.
There were two patients with malignant changes, one maxillary tumor was treated by anterior maxillectomy, obturator and post-operative radiation therapy and the other in the mandible was treated by selective neck dissection and hemi-mandibulectomy. Both patients are alive and cancer free at 86 and 82 months respectively.
Discussion
A major obstacle in rationalizing therapy for KCOT is the inability to know whether all KCOTs share the same propensity for recurrence, and if not, how to identify those at higher risk. Recurrence may occur for 2 reasons. First, they may arise from micro cysts or epithelial islands left behind after enucleation. These may be part of the original lining or epithelial islands present in the connective tissue wall of the cyst or in overlying mucosa that are left behind. It is well recognized that syndromal patients (basal cell nevi syndrome), have a high incidence of daughter/satellite cysts, which make their complete removal more complex. Second, recent laboratory research has suggested that a knowledge of the molecular and genetic alterations associated with KCOTs may predict individual biological behavior [10] . Vered et al. [5] suggest that the immuneprofile of Sonic hedgehog (SHH)-related proteins and the SHH-induced bcl-2 oncoprotein may be able to define the individual KCOT phenotype and biologic behavior. These authors reviewed the current literature regarding possible future molecular oriented treatment. In 2009, Pan and Li showed that KCOTs with PTCH1-truncation causing mutations had significantly higher Ki67 labeling with increased proliferative activity, which may relate to a phenotype with higher recurrence potential [11] . At the present time, however, these laboratory findings are not available or useful to the clinician faced with an individual patient.
There is also little scientific evidence in the literature to guide the surgeon in determining the best course of treatment for KCOTs. A recent paper suggests an association between larger, multilocular and presumably more aggressive lesions in younger age patients (\41 years) [12] . A systematic review of the literature to assess treatments with respect to the likelihood of recurrence was published in 2000. The authors reviewed 2,290 studies but only 14 met their 4 inclusion criteria and these were all retrospective case series. Resection had a recurrence rate of 0 %, and enucleation with adjunctive therapies (Carnoy's/ decompression) had recurrence rate 1-8.7 %, while enucleation alone had recurrences of 17-56 %. The authors concluded that resection or enucleation with adjunctive therapies had lower recurrence rates than simple enucleation [13] . A Cochrane Database Systematic Review published in 2010 attempted to assess treatment strategies for KCOT, no randomized controlled trials that met inclusion criteria were identified. Due to the lack of randomized controlled trials the authors felt no conclusions could be reached about the effectiveness or otherwise of the treatments for KCOT [14] . The clinician therefore has to rely on large retrospective case series and their own experience in deciding when resection might be the appropriate treatment. A small retrospective study of 40 KCOT patients reported three patients (7.5 %) treated by resection with no recurrence. The indications for resection, however, were not described [15] . A report of 31 cases of mandibular KCOTs all treated by intraoral resection without continuity defects showed no recurrence on follow up (2-8 years) [16] . In a larger series of 255 patients, 52 (20.4 %) were treated with resection with no recurrence. Recurrence rates in patients treated by enucleation, enucleation ? Carnoy's solution and decompression ? enucleation, were 17.8, 6.7 and 0 % respectively. Here the authors concluded that radical excision group had no recurrences but gave the highest patient morbidity and recommended its use only in patients who had multiple recurrences after previous treatments [17] .
Although the literature suggests that the recurrence rate following resection is zero [13] , it has a significant morbidity and is rarely the first choice of treatment for a benign KCOT. Usually resection is reserved for lesions which have recurred after multiple ''conservative'' surgeries and/ or where the KCOT is no longer contained in bone. In clinical practice this situation occurs most frequently in relation to perforation of the bony cortex and involvement of soft tissues with potential for involvement of vital structures such as the orbit and lateral skull base (Fig. 2) . As 70.5-76.5 % of KCOTs occur in the mandible [3, 4] and most commonly in the angle/wisdom tooth, perforation risks involvement of the medial pterygoid muscle (Fig. 3) . In a retrospective study of 82 OKCs over a 25 year period, Stoelinga [18] found a large number of OKCs in the retromolar/vertical ramus area. He also found that 50 % of the OKCs in this location had clusters of epithelial islands in the overlying mucosa. He postulates that in this region recurrent keratocysts may arise from these epithelial islands in the overlying mucosa or from residual remnants of the original cyst lining. In this situation, Stoelinga's protocol included excision of the overlying mucosa with the cyst and application of Carnoy's solution, and where lingual perforations were present he advocated electrocautery to eliminate epithelial remnants and prevent soft tissue recurrence. Although this may be a reasonable approach in microscopic disease of the mucosa/periosteum, once the KCOT involves muscle or other soft tissues, enucleation, peripheral ostectomy, decompression and mucosal excision are inadequate since they do not address the muscle involvement. At this stage KCOTs may behave Fig. 2 a Panorex shows recurrent KCOT in the iliac crest bone graft, a second recurrence in is seen at the distal root of tooth #19. Patient had numerous previous surgeries. b Coronal MRI demonstrates that the KCOT has perforated both buccal and lingual plates of the vertical ramus and is involving the masseter, medial pterygoid and lateral pterygoid muscles. c Sagittal MRI demonstrates the KCOT abutting the skull base in the region of the temporal lobe more aggressively with a more rapid expansion. Extension from the pterygoid muscles to the infratemporal fossa, lateral pharyngeal space, skull base and orbit are all possible, and elimination of the KCOT will mandate a wide local excision with a margin of normal muscle. Similarly in the maxilla, posterior perforation of the sinus wall with involvement of the pterygoid plates will require posterior maxillectomy with a margin including the attached lateral and medial pterygoid muscles. The thin wall of the maxillary sinus allows earlier perforation by the KCOT, which may reach a large size in the maxillary sinus before being diagnosed.
Surgical elimination of the KCOT at this stage is more complex due to the problems of accessing the pterygoid space, bleeding from the pterygoid plexus of veins and branches of the maxillary artery, the presence of fibrous scar tissue from previous procedures and defining the margins of the lesion. Frequently the involved muscle is very stiff due to fibrosis that may be due to inflammation, infiltration or infection, which makes surgery more difficult. Case 7 illustrates this dilemma with a multiply operated patient who underwent resection elsewhere and still recurred in his bone graft but also had recurrence in the pterygoid/infratemporal spaces approaching the skull base (Fig. 2) . Stoelinga attributes these recurrences in bone grafts as proof of the presence of microscopic epithelial islands in the overlying mucosa that is left behind during the cyst removal [18] . Despite the fact that most large series report the recurrence of KCOT following resection as zero [13] , recurrence of KCOT in bone grafts after resection is reported [19, 20] and Case 7 supports the fact that KCOT may recur even following resection and reconstruction.
Another possibility to explain recurrence is the presence of multifocal disease, which Stoelinga reports in 3/80 of his series of patients who did not suffer from Basal Cell Nevi Syndrome [18] . Boyne et al. [21] reported 7 cases with multiple recurrent OKCs operated over 10-21 years; six of whom underwent hemimandibulectomy. The histologic examination of the mandibles showed cyst formation at distant sites from the original cyst in all cases and they postulated that the lesions were multifocal. It is not clear Fig. 3 a Recurrent KCOT involves the sigmoid notch and subsigmoid extends into medial pterygoid muscle. b Post operative panorex shows resection and costochondral graft how the authors determined whether OKC/KCOT is primarily multifocal or whether the multifocal disease was a result of ''seeding'' of distant sites by the original conservative treatments including curettage. In either case the need for segmental resection with radical excision of involved overlying soft tissues would seem to be the only logical way to eradicate disease in these cases. Although the use of marginal mandibular resection is reported [16] , the size of our KCOTs precluded this in all but one case.
Malignant change in KCOT is rare and the two cases listed in this paper were previously reported in a series of 6 intra-osseous carcinomas from the University of Maryland [22] . In this review 134 published cases of intraosseous carcinoma were found, of which 82 arose in odontogenic cysts. How many arose specifically in KCOT was not specified. In another review of malignant odontogenic tumors, only 1 of 9 was a carcinoma arising in a keratocyst [23] . These tumors are more common in the mandible and are treated with segmental resection with selective neck dissection for the N0 neck or modified radical neck dissection if positive nodes are present. Post operative radiation therapy is recommended and was given to both our cases. Two year survival rates are reported as 53-63 % [24, 25] . Some authorities believe that carcinomatous change is the only indication for resection, stating that resection with its morbidity may be too radical and represent an overtreatment of a benign lesion [26] .
In reviewing our series it is apparent that other than the two cases of malignant change in KCOT, the main indication for resection was the location of the cyst in the vertical ramus of the mandible or posterior maxilla with bony perforation and involvement of the pterygoid musculature. Most of the mandibular cases had previously recurred multiple times. How much of the perforation and soft tissue involvement was of iatrogenic causes due to prior surgeries, or related to the inherent aggressive nature of the KCOT cannot be assessed. In these cases segmental resection of the involved mandible with a wide local excision of the involved pterygoid muscle attempting to keep a margin of uninvolved muscle around the tumor was our treatment of choice. In the maxilla, posterior maxillectomy with the involved pterygoid muscle with a margin of normal tissue is required. In most maxillary cases the oro-antral fistula created can be closed with the buccal fat pad.
The number of patients treated with resection (12/80 or 15 %) in our series may appear high, but it should be noted that as a tertiary referral center, many patients are referred to our unit because of the size or location of the tumor, or the fact that they have recurrent tumors. Despite the morbidity of resection for a benign lesion we believe that this modality of treatment has its place in the management of KCOT. Although most published reviews have recommended resection for patients with multiple recurrences, 3 of 10 of our cases had no previous treatment. Two were in the vertical ramus of the mandible extending to the condyle with lingual perforations and one a maxillary lesion with involvement of the pterygoid plates. In patients with recurrent KCOTs, tissue fibrosis and multifocal lesions makes eradication of the disease more difficult even with radical resection. Whether lesions that have recurred multiple times truly represent a more aggressive phenotype or inadequate prior treatment is not known at the present time. We consider involvement of the pterygoid muscle by KCOT is indication for wider resection. Patients with malignant change in a KCOT are also obviously treated by resection.
